Nonresectional regional therapies for metastatic colorectal cancer to the liver.
Cary Jo R SchlickRyan P MerkowCary Jo R SchlickPublished in: Journal of surgical oncology (2019)
The liver is the second leading site of colorectal cancer metastases, following the lymph nodes. Although metastatic resection for colorectal cancer liver metastases has been shown to improve survival, many patients cannot undergo surgery. Several nonsurgical therapies are available in these situations, however high-quality evidence comparing the effectiveness of these therapies is sparse. Here, we review the currently available evidence in support of nonresectional regional therapies for colorectal metastases to the liver.
Keyphrases
- liver metastases
- metastatic colorectal cancer
- lymph node
- end stage renal disease
- squamous cell carcinoma
- newly diagnosed
- ejection fraction
- small cell lung cancer
- minimally invasive
- randomized controlled trial
- systematic review
- chronic kidney disease
- prognostic factors
- coronary artery bypass
- patient reported outcomes
- neoadjuvant chemotherapy
- free survival
- percutaneous coronary intervention